{"status": "Ok", "redirect_url": "https://www.prnewswire.com//news-releases/abbvie-announces-european-commission-approval-of-skyrizi-risankizumab-for-the-treatment-of-pediatric-patients-with-moderate-to-severe-plaque-psoriasis-302807055.html", "message": "News view counter 811148 successfully enlarged"}